Fresenius SE Comprehensive Income 2016-2024 | FSNUY

Fresenius SE comprehensive income for the quarter ending June 30, 2024 was $0.274B, a 128.05% increase year-over-year.

  • Fresenius SE comprehensive income for 2023 was $0.019B, a 95.46% decline from 2022.
  • Fresenius SE comprehensive income for 2022 was $0.429B, a 181.27% decline from 2021.
  • Fresenius SE comprehensive income for 2021 was $-0.528B, a 59.3% decline from 2020.

Fresenius SE Comprehensive Income 2016-2024 | FSNUY

  • Fresenius SE comprehensive income for 2023 was $0.019B, a 95.46% decline from 2022.
  • Fresenius SE comprehensive income for 2022 was $0.429B, a 181.27% decline from 2021.
  • Fresenius SE comprehensive income for 2021 was $-0.528B, a 59.3% decline from 2020.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$17.8B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$7B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$3.8B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.8B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$237M
Daxor (DXR)$46M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$11M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M